Loading...
Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
BACKGROUND: To describe and analyze the patterns of adverse events associated with dipeptidyl peptidase-4 inhibitors (DPP-4is) (sitagliptin, saxagliptin, linagliptin, vildagliptin, and alogliptin) from the FDA Adverse Event Reporting System (FAERS) and to highlight areas of safety concerns. METHODS:...
Na minha lista:
| Udgivet i: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493367/ https://ncbi.nlm.nih.gov/pubmed/32938499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-020-00447-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|